SampleIDa Water Works/Sample
description/Coagulant dose concentration
Month Calibration method
M1aPeak Absorbance
@ 690 nm
M2Peak
Area @ 690 nm
M3Ratio of peak absorbances
(A690nm/A520nm)
“M1 and M2”
combined data
ObservedConca (µg/L) Observed% RSD ObservedConc (µg/L) Observed% RSD ObservedConc (µg/L) Observed% RSD Calculated MeanConc (µg/L) Calculated
SD(µg/L)
Calculated
%RSD
4R Wiggins: raw May 3.16 7.09 4.21 4.83 38.2 1.03 3.69 0.74 20.15
5R Wiggins: raw May 4.23 10.8 3.73 15.1 nda 0.92 3.98 0.35 8.88
Mean     3.70   3.97   38.20        
SD     0.76   0.34            
% RSD     20.48   8.55            
6F Wiggins: potable May 9.14 3.90 10.30 3.82 65.30 1.26 9.72 0.82 8.44
7F Wiggins: potable May 1.38 2.35 1.11 26.10 64.60 1.76 1.25 0.19 15.33
8F Wiggins: potable May 2.38 2.03 2.58 7.37 55.60 0.40 2.48 0.14 5.70
Mean     4.30   4.66   61.83        
SD     4.22   4.94   5.41        
% RSD     98.17   105.86   8.75        
9B Wiggins: raw: Jar test May 12.70 6.62 11.00 6.46 nd 3.01 11.85 1.20 10.14
10B Wiggins: raw: Jar test May 7.84 5.25 8.61 3.01 28.20 0.58 8.23 0.54 6.62
Mean     10.27   9.81   28.20        
SD     3.44   1.69            
% RSD     33.46   17.24            
11O Wiggins raw:Jar test: optimal dose May 22.70 7.86 21.30 7.34 nd 3.61 22.00 0.99 4.50
12O Wiggins raw:Jar test: optimal dose May 17.21           17.21    
13O Wiggins/ optimal dose May 14.10 3.01 19.10 1.50 nd 3.01 16.60 3.54 21.30
Mean     18.00   20.20     3.31      
SD     4.35   1.56     0.42      
% RSD     24.19   7.70     12.82      
                       
14 Wiggins raw:Jar test;30% overdose May 1.90           1.90    
15 Wiggins raw:Jar test: 60% overdose May 0.29 16.00 0.47 31.30 54.30 0.37 0.38 0.12 32.92
16 Wiggins raw:Jar test: 100% overdose May 2.79 11.70 4.17 21.70 nd 2.39 3.48 0.98 28.04
20R Wiggins: raw June 3.60 4.34 4.11 9.75 48.20 0.98 3.86 0.36 9.35
20F Wiggins: potable June  0.713  3.39  1.53  2.04  15.3 0.38 1.12 0.58 51.51
21B Wiggins: raw:Jar test June 5.12 12.60 5.59 5.60 40.50 3.45 5.36 0.33 6.21
22B Wiggins: raw:Jar test June 1.49 4.90 1.95 5.20 22.70 0.17 1.72 0.33 18.91
Mean     3.31   3.77 5.40 31.60        
SD     2.57   2.57 0.28 12.59        
% RSD     77.66   68.27 5.24 39.83        
230 Wiggins: raw:Jar test: optimal June 0.53 8.90 0.64 15.00 13.20 0.44 0.58 0.08 14.15
24 Wiggins: raw:Jar test: 30% overdose June 3.64 8.10 4.41 2.72 42.80 1.01 4.03 0.54 13.53
25 Wiggins: raw:Jar test: 30% overdose June 4.77 1.20 5.88 1.17 47.30 0.65 5.33 0.78 14.74
26 Wiggins: raw: Jar test: 30% overdose June 1.78 5.09 2.16 8.85 30.90 5.46 1.97 0.27 13.64
Mean     3.40   4.15 4.25 40.33        
SD     1.51   1.87 4.06 8.47        
% RSD     44.45   45.15 95.63 21.01        
27 Wiggins: raw:Jar test: 60% overdose June 5.65 0.48 7.35 0.07 35.60 0.50 6.50 1.20 18.49
28 Wiggins: raw:Jar test:100% overdose June 1.61 5.82 0.72 1.70 11.90 1.03 1.17 0.63 53.77
                       
32R   July 3.93 7.19 4.00 7.57 47.20 0.97 3.97 0.05 1.25
32F   July 1.27 4.27 1.80 0.22 9.44 0.73 1.54 0.37 24.41
33B Wiggins: raw:Jar test July 5.51 0.63 7.21 1.79 54.20 0.80 6.36 1.20 18.90
34B Wiggins: raw:Jar test July 12.90 4.84 12.00 7.20 44.10 2.73 12.45 0.64 5.11
Mean     9.21   9.61   49.15        
SD     5.23   3.39   7.14        
% RSD     56.77   35.26   14.53        
350 Wiggins optimal July 1.08 8.09 0.41 19.50 7.85 1.12 0.75 0.47 63.32
36 Wiggins 30% overdose July 1.12 4.15 1.19 24.40 6.44 1.89 1.16 0.05 4.29
37 Wiggins 60% overdose July 2.48 2.51 3.53 1.24 9.58 0.39 3.01 0.74 24.71
38 Wiggins 60% overdose July 0.19 12.00 0.74 4.01 9.71 0.17 0.46 0.39 83.45
39 Wiggins 60% overdose July 3.11 4.46 5.18 2.99 8.03 1.20 4.15 1.46 35.31
Mean     1.93   3.15   9.11        
SD     1.54   2.25   0.93        
% RSD     79.76   71.32   10.26        
40 Wiggins 100% overdose July 2.70 2.52 2.16 6.52 10.20 1.26 2.43 0.38 15.71
1R DV Harris: raw May 6.79 7.15 6.61 7.72 nd 2.08 6.70 0.13 1.90
1F DV Harris: potable May 1.85 8.84 2.34 12.00 17.20 0.95 2.10 0.35 16.54
17R DV Harris: raw June 5.48 2.93 8.14 0.79 5.32 2.39 6.81 1.88 27.62
17F DV Harris: potable June 0.99 33.00 2.71 2.43 12.20 0.28 1.85 1.22 65.85
29R DV Harris: raw July 18.10 9.70 18.90 8.92 62.00 6.20 18.50 0.57 3.06
29F DV Harris: potable July 0.82 5.52 0.40 6.57 13.40 0.40 0.61 0.30 49.07
2R Hazelmere: raw May 1.43 2.06 2.30 0.41 23.30 0.33 1.87 0.62 32.99
2F Hazelmere: potable May 2.70 7.91 4.20 7.67 15.80 1.36 3.45 1.06 30.74
18R Hazelmere: raw June 17.25 0.95 23.80 0.69 52.20 0.83 20.53 4.63 22.57
18F Hazelmere potable June 0.22 34.10 0.67 16.50 10.70 0.40 0.44 0.31 70.79
30R Hazelmere: raw July 1.78 4.33 2.31 0.65 16.80 0.69 2.05 0.37 18.33
30F Hazelmere: potable July 0.72 5.33 1.25 4.99 8.50 0.47 0.98 0.38 38.23
3R Durban Heights: raw May 13.30 4.70 13.40 6.36 nd 0.31 13.35 0.07 0.53
3F Durban Heights:potable May 2.01 23.80 2.87 15.10 57.00 2.12 2.44 0.61 24.92
19R Durban Heights:potable June 2.36 12.70 3.50 11.70 16.50 1.65 2.93 0.81 27.51
19F Durban Heights:potable June 0.89 8.68 0.95 9.66 13.80 0.40 0.92 0.04 4.61
31R Durban Heights:raw July 1.54 4.33 2.31 0.65 16.80 0.69 1.93 0.54 28.28
31F Durban Heights:potable July 8.02 1.54 11.20 0.99 26.00 0.29 9.61 2.25 23.40
aconc: Concentration; ID: Identity; nd: Not Detected.
Table 2: The observed levels of poly-DADMAC for all the samples.